Trial Profile
Clinical Trials Insight: 700049226
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Sep 2009
Price :
$35
*
At a glance
- Drugs Esomeprazole/naproxen (Primary)
- Indications Arthritis; Musculoskeletal pain; NSAID-induced gastrointestinal damage
- Focus Adverse reactions; Pharmacokinetics
- 26 Sep 2009 New trial record.